TPP1 and juvenile neuronal ceroid lipofuscinosis: The efficacy of tripeptidyl peptidase 1 (cerliponase alfa) on the walking ability of Batten disease patients demonstrates that enzyme replacement therapy for diseases that affect the brain is theoretically possible.